ERBB2 and breast cancer: Furthermore, we also found reduced PEDF expression in the presence of post-menopausal oestrogen levels in BC cells in vitro, with PEDF anti-metastatic function enhanced under pre-menopausal conditions for TNBC cells, and under post-menopausal conditions for ER+/HER2- BC cells (manuscript submitted).